Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

CompletedOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

October 28, 2023

Study Completion Date

October 28, 2023

Conditions
Infertility, Female
Interventions
OTHER

Other: Non intervention

Non intervention

Trial Locations (15)

Unknown

Pyeongchon Maria, 8/9F, Olympic Sports Center120, Dongan-ro, Dongan-gu, Anyang

Dream-I clinic, 45-17, Huimang-ro 46beon-gil, Baebang-eup, Asan

Centum Eroom Woman Clinic, 10F, Centum Tower Medical, 20, Centum-2-ro, Haeundae-gu, Busan

Eroom women's clinic, 25, Seomyeon-ro, Busanjin-gu, Busan

Seoul Women's Hospital, 7, Munjeong-ro, Seo-gu, Daejeon

Creation And Love Women's Hospital, 957, Mujin-daero, Seo-gu, Gwangju

Mirae and Heemang Women's Hospital, 7F, Dana Medical Center, 68, Jukbong-daero, Seo-gu, Gwangju

Design Hospital, Jeonju

Trinium Woman's Hospital, 1834, MainTower, Hannuridae-ro, Sejong

CHA university Bundang medical center, 59, Yatap-ro, Bundang-gu, Seongnam

Seoul Nation University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam

M Fertility Center, 12F, 407, Teheran-ro, Gangnam-gu, Seoul

MariaS (Sangbong), 267, Mangu-ro, Jungnang-gu, Seoul

Mizmedi Hospital, 295, Gangseo-ro, Gangseo-gu, Seoul

Seoul Maria Fertility Hospital, 20, Cheonho-daero, Dongdaemun-gu, Seoul

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY